our history

Effective April 1, 2019, the Global Research Services (GRS) operating unit of FHI 360 became an independent, commercial organization: FHI Clinical. As an FHI 360 subsidiary, we benefit from our 50+ year history of clinical research and success creating and growing contract research organizations (CROs).

The FHI Clinical project team has been involved in approximately 500 studies in more nearly 75 countries worldwide.

Our team of industry veterans combine their therapeutic knowledge and clinical expertise to help determine where our expertise will have the greatest impact. Every person at FHI Clinical is passionate about finding solutions to the challenges that have kept life-saving medicines from at-risk populations. We’re problem solvers, forward thinkers and on-the-ground community members, and we’re dedicated to helping our clients achieve their research goals.

Since our launch, the FHI Clinical team has grown by over

0 x

our EVOLUTION

1971
FHI 360 grows out of research at the University of North Carolina to develop safe and effective family planning methods
1980s
FHI 360 expands its scope to respond to the HIV/AIDS epidemic

Clinical Research International (CRI), the first multinational, full-service CRO, is formed by FHI 360

1990
CRI is sold to ClinTrials Research, and the funds are used to establish the FHI Foundation endowment
1999
FHI 360 acquires PharmaLink, which would later become Novella Clinical, growing to employ more than 800 staff
2008
The Global Research Services (GRS) department is formed within FHI 360
2013
Novella Clinical is sold to Quintiles
2019
FHI Clinical is formed when GRS is spun off from FHI 360, effective April 1
2022
FHI Clinical acquires the clinical trials business of Triclinium Clinical Development Proprietary Limited (TCD), a full-service, South Africa-based CRO, effective February 8

our EVOLUTION

1971
FHI 360 grows out of research at the University of North Carolina to develop safe and effective family planning methods
1971
1980s
FHI 360 expands its scope to respond to the HIV/AIDS epidemic

FHI 360 forms Clinical Research International (CRI), the first multinational, full-service CRO

1980s
1990
CRI is sold to ClinTrials Research, and the funds are used to establish the FHI Foundation endowment
1990
1999
FHI 360 acquires PharmaLink, which would later become Novella Clinical, growing to employ more than 800 staff
1999
2008
The Global Research Services (GRS) department is formed within FHI 360
2008
2013
Novella Clinical is sold to Quintiles
2013
2019
FHI Clinical is formed when GRS is spun off from FHI 360, effective April 1
2019
2022
FHI Clinical acquires the clinical trials business of Triclinium Clinical Development Proprietary Limited (TCD), a full-service, South Africa-based CRO, effective February 8
2022

The FHI 360 Family of Companies​

As an independent, commercial CRO within the FHI 360 family, FHI Clinical has a proven history of conducting research in hard-to-reach markets.

FHI Clinical

Manages complex clinical research in resource-limited settings around the world

FHI Ventures

Invests in and accelerates the growth of early-stage social enterprises

FHI Partners

Creates customized solutions that make FHI 360’s expertise and services more accessible to corporations and foundations

FHI Solutions

Offers programs focused on nutrition and food security

Gold Star Kenya

Partners with the public and private sectors in Kenya to address HIV/AIDS, tuberculosis, malaria, maternal and child health, family planning and reproductive health and noncommunicable diseases

FH India

Designs and carries out public health, nutrition and education programs in India

AHNi

Provides health and development research and services through technical assistance from the Government of Nigeria and other stakeholders